Foresite Capital Management IV, LLC
Source: SEC Form 13F · as of Mar 2026Foresite Capital Management IV, LLC holds 5 biotech & pharma companies tracked by BioSniper, totaling $197.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$197.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Pharvaris N.V. (PHVS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PHVSPharvaris N.V. | 4,778,581 | $135.0M |
| CYTKCYTOKINETICS INC | 503,295 | $33.2M |
| LYELLyell Immunopharma, Inc. | 800,399 | $16.1M |
| ALECAlector, Inc. | 3,887,200 | $8.4M |
| MAZEMaze Therapeutics, Inc. | 156,901 | $4.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.